Skip to main content

Advertisement

SpringerLink
Log in

Chemokines and their receptors in infectious disease

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ahuja SK, Murphy PM (1993) Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. J Biol Chemn 268: 20691

    CAS  Google Scholar 

  2. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996) CC CKR5: a RANTES, MIP-1 alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272: 1955

    PubMed  CAS  Google Scholar 

  3. Al Sharif F, Oilier WE, Hajeer AH (1999) A rare polymorphism at position −28 in the human RANTES promoter. Eur J Immunogenet 26: 3734

    Google Scholar 

  4. Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, Arenzana-Seisdedos F (1997) HIV coreceptor downregulation as antiviral principle: SDF-1alpha-de-pendent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 186: 139

    PubMed  CAS  Google Scholar 

  5. Arya SK, Ginsberg CC, Davis-Warren A, D’Costa J (1999) In vitro phenotype of SDF1 gene mutant that delays the onset of human immunodeficiency virus disease in vivo. J Hum Virol 2: 133

    PubMed  CAS  Google Scholar 

  6. Baba M, Nishimura O, Kanzaki N, Okamoto M, Sawada H, Iizawa Y, Shiraishi M, Aramaki Y, Okonogi K, Ogawa Y, Meguro K, Fujino M (1999) A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci USA 96: 5698

    PubMed  CAS  Google Scholar 

  7. Bai X, Chen JD, Yang AG, Torti F, Chen SY (1998) Genetic co-inactivation of macrophage- and T-tropic HIV-1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines. Gene Ther 5: 984

    PubMed  CAS  Google Scholar 

  8. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, Mesri EA, Gerhengorn MC (1998) G-protein-coupled receptor of Kaposi’s sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator [published erratum appears in Nature (1998) 392:210]. Nature 391: 86

    PubMed  CAS  Google Scholar 

  9. Balotta C, Bagnarelli P, Corvasce S, Mazzucchelli R, Colombo MC, Papagno L, Santambrogio S, Ridolfo AL, Violin M, Berlusconi A, Velleca R, Facchi G, Moroni M, Clementi M, Galli M (1999) Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stro-mal-derived factor 1 chemokine gene polymorphism analysis. J Infect Dis 180: 285

    PubMed  CAS  Google Scholar 

  10. Benkirane M, Jin DY, Chun RF, Koup RA, Jeang KT (1997) Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J Biol Chem 272: 30603

    PubMed  CAS  Google Scholar 

  11. Berger EA, Doms RW, Fenyo EM, Korber BT, Littman DR, Moore JP, Sattentau QJ, Schuitemaker H, Sodroski J, Weiss RA (1998) A new classification for HIV-1. Nature 391: 240

    PubMed  CAS  Google Scholar 

  12. Berger EA, Murphy PM, Farber JM (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17: 657–700

    PubMed  CAS  Google Scholar 

  13. Biti R, French R, Young J, Bennetts B, Stewart G, Liang T (1997) HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat Med 3: 252

    PubMed  CAS  Google Scholar 

  14. Bodaghi B, Jones TR, Zipeto D, Vita C, Sun L, Laurent L, Arenzana-Seisdedos F, Virelizier JL, Michelson S (1998) Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 188:855

    PubMed  CAS  Google Scholar 

  15. Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL, Siani MA, Sasaki T, Williams TJ, Gray PW, Moore PS, Chang Y, Weis RA (1997) Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278: 290

    PubMed  CAS  Google Scholar 

  16. Bridger GJ, Skerlj RT, Padmanabhan S, Martellucci SA, Henson GW, Struyf S, Witvrouw M, Schols D, De Clerc E (1999) Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4. J Med Chem 42: 3971

    PubMed  CAS  Google Scholar 

  17. Chen JD, Bai X, Yang AG, Cong Y, Chen SY (1997) Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy. Nat Med 3:1110

    PubMed  CAS  Google Scholar 

  18. Chen Z, Kwon D, Jin Z, Monard S, Telfer P, Jones MS, Lu CY, Aguilar RF, Ho DD, Marx PA (1998) Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J Exp Med 188: 2057

    PubMed  CAS  Google Scholar 

  19. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J (1996) The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85: 1135

    PubMed  CAS  Google Scholar 

  20. Clegg AO, Ashton LJ, Biti RA, Badhwar P, Williamson P, Kaldor JM, Stewart GJ (2000) CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group. Aids 14: 103

    PubMed  CAS  Google Scholar 

  21. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811

    PubMed  CAS  Google Scholar 

  22. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O (1995) Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269: 1583

    PubMed  CAS  Google Scholar 

  23. Daelemans D, Schols D, Witvrouw M, Pannecouque C, Hatse S, Dooren S van, Hamy F, Klimkait T, de Clercq E, VanDamme AM (2000) A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry. Mol Pharmacol 57: 116

    PubMed  CAS  Google Scholar 

  24. Damon I, Murphy PM, Moss B (1998) Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. Proc Natl Acad Sci USA 95: 6403

    PubMed  CAS  Google Scholar 

  25. Datema R, Rabin L, Hincenbergs M, Moreno MB, Warren S, Linquist V, Rosenwirth B, Seifert J, McCuner JM (1996) Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry. Antimicrob Agents Chemother 40: 750

    PubMed  CAS  Google Scholar 

  26. Davis CB, Dikic I, Unutmaz D, Hill CM, Arthos J, Siani MA, Thompson DA, Schlessinger J, Littman DR (1997) Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 186: 1793

    PubMed  CAS  Google Scholar 

  27. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O’Brien SJ (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study [published erratum appears in Science (1996) 274: 1069]. Science 273: 1856

    PubMed  CAS  Google Scholar 

  28. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381: 661

    PubMed  CAS  Google Scholar 

  29. Doranz BJ, Grovit-Ferbas K, Sharron MP, Mao SH, Goetz MB, Daar ES, Doms RW, O’Brien WA (1997) A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J Exp Med 186: 1395

    PubMed  CAS  Google Scholar 

  30. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85: 1149

    PubMed  CAS  Google Scholar 

  31. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA (1996) HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381: 667

    PubMed  CAS  Google Scholar 

  32. Easterbrook PJ, Rostron T, Ives N, Troop M, Gazzard BG, Rowland-Jones SL (1999) Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. J Infect Dis 180: 1096

    PubMed  CAS  Google Scholar 

  33. Este JA, Cabrera C, Blanco J, Gutierrez A, Bridger G, Henson G, Clotet B, Schols D, De Clercq E (1999) Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4. J Virol 73: 5577

    PubMed  CAS  Google Scholar 

  34. Faure S, Meyer L, Costagliola D, Vaneensberghe C, Genin E, Autran B, Delfraissy JF, McDermott DH, Murphy PM, Debre P, Theodorou I, Combadiere C (2000) Rapid progression to AIDS in HIV(+) individuals with a structural variant of the chemokine receptor CX(3)CR1. Science 287: 2274

    PubMed  CAS  Google Scholar 

  35. Feng Y, Broderi CC, Kennedy PE, Berger EA (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272: 872

    PubMed  CAS  Google Scholar 

  36. Furci L, Scarlatti G, Burastero S, Tambussi TG, Colognesi C, Quillent C, Longhi R, Loverro P, Borgonovo B, Gaffi D, Carrow E, Malnati M, Lusso P, Siccardi AG, Lazzarin A, Beretta A (1997) Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele. J Exp Med 186: 455

    PubMed  CAS  Google Scholar 

  37. Gao JL, Murphy PM (1994) Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J Biol Chem 269: 28539

    PubMed  CAS  Google Scholar 

  38. Gao JL, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE, Cooper S, Tiffany HL, Westphal H, Kwon-Chung J, Murphy PM (1997) Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 185: 1959

    PubMed  CAS  Google Scholar 

  39. Gonzalez E, Bamshad M, Sato N, Mummidi S, Dhanda R, Catano G, Cabrera S, McBride M, Cao XH, Merril G, O’Connell P, Bowden DW, Freedman BI, Anderson SA, Walter EA, Evans JS, Stephan KT, Clark RA, Tyagi S, Ahuja SS, Dolan MJ, Ahuja SK (1999) Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci USA 96: 12004

    PubMed  CAS  Google Scholar 

  40. Gonzalez MA, Serrano F, Llorente M, Abad JL, Garcia-Ortiz MJ, Bernad A (1998) A hammerhead ribozyme targeted to the human chemokine receptor CCR5. Biochem Biophys Res Commun 251: 592

    PubMed  CAS  Google Scholar 

  41. Gordon CJ, Muesing MA, Proudfoot AE, Power CA, Moore JP, Trkola A (1999) Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J Virol 73: 684

    PubMed  CAS  Google Scholar 

  42. Gu L, Tseng S, Horner R, Tarn C, Loda M, Rollins BJ (2000) Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404: 407

    PubMed  CAS  Google Scholar 

  43. Hajeer AH, Sharif F al, Oilier WE (1999) A polymorphism at position −403 in the human RANTES promoter. Eur J Immunogenet 26: 375

    PubMed  CAS  Google Scholar 

  44. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hofmann W, Newman W, Mackay CR, Sodroski J, Gabuzda D (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385: 645

    PubMed  CAS  Google Scholar 

  45. Hesselgesser J, Ng HP, Liang M, Zheng W, May K, Bauman JG, Monahan S, Islam I, Wei GP, Ghannam A, Taub DD, Rosser M, Snider RM, Morrissey MM, Perez HD, Horuk R (1998) Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor. J Biol Chem 273: 15687

    PubMed  CAS  Google Scholar 

  46. Hesselgesser J, Taub D, Baskar P, Greenberg M, Hoxie J, Kolson DL, Horuk R (1998) Neuronal apoptosis induced by HIV-1 gpl20 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr Biol 8: 595

    PubMed  CAS  Google Scholar 

  47. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH (1993) A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261: 1182

    PubMed  CAS  Google Scholar 

  48. Howard OM, Oppenheim JJ, Hollingshead MG, Covey IM, Bigelow J, McCormack JJ, Buckheit RW Jr, Clanton DJ, Turpin JA, Rice WG (1998) Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application. J Med Chem 41: 2184

    PubMed  CAS  Google Scholar 

  49. Huang L, Bosch I, Hofmann W, Sodroski J, Pardee AB (1998) Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J Virol 72: 8952

    PubMed  CAS  Google Scholar 

  50. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, Koup RA (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2: 1240

    PubMed  CAS  Google Scholar 

  51. Huffnagle GB, McNeil LK, McDonald RA, Murphy JW, Toews GB, Maeda N, Kuziel WA (1999) Cutting edge: role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococ-cus neoformans. J Immunol 163: 4642

    PubMed  CAS  Google Scholar 

  52. Isegawa Y, Ping Z, Nakano K, Sugimoto N, Yamanishi K (1998) Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. J Virol 72: 6104

    PubMed  CAS  Google Scholar 

  53. Kinter A, Catanzaro A, Monaco J, Ruiz M, Justement J, Moir S, Arthos J, Oliva A, Ehler L, Mizell S, Jackson R, Ostrowski M, Hoxie J, Offord R, Fauci AS (1998) CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction. Proc Natl Acad Sci USA 95: 11880

    PubMed  CAS  Google Scholar 

  54. Kirshner JR, Staskus K, Haase A, Lagunoff M, Ganem D (1999) Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi’s sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis. J Virol 73: 6006

    PubMed  CAS  Google Scholar 

  55. Kledal TN, Rosenkilde MMS, Coulin F, Simmons G, Johnson AH, Alouani S, Power CA, Luttichau HR, Gerstoft J, Clapham PR, Clark LI, Wells T, Schwartz TW (1997) A broad-spectrum chemokine antagonist encoded by Kaposi’s sarcoma-associated herpesvirus. Science 277: 1656

    PubMed  CAS  Google Scholar 

  56. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, Deutsch L, Phair J, Neumann AU, Ho DD (1998) A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 4: 350

    PubMed  CAS  Google Scholar 

  57. Kostrikis LG, Neumanni AU, Thomson B, Korber BT, McHardy P, Karanicolas R, Deutsch L, Huang Y, Lew JF, Mcintosh K, Pollack H, Borkowsky W, Spiegel HM, Palumbo P, Oleske J, Bardeguez A, Luzuriaga K, Sullivan J, Wolinsky SM, Koup RA, Ho DD, Moore JP (1999) A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol 73: 10264

    PubMed  CAS  Google Scholar 

  58. Kurihara T, Warr G, Loy J, Bravo R (1997) Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 186: 1757

    PubMed  CAS  Google Scholar 

  59. Kusunoki A, Wada A, Kurosaki N, Kimura T, Takai K, Yamamoto N, Takaku H (1999) Antisense oli-godeoxynucleotide complementary to CXCR4 mRNA block replication of HIV-1 in COS cells. Nucleosides Nucleotides 18: 1705

    PubMed  CAS  Google Scholar 

  60. LaCasse RA, Follis KE, Trahey M, Scarborough JD, Littman DR, Nunberg JH (1999) Fusion-competent vaccines: broad neutralization of primary isolates of HIV. Science 283: 357

    PubMed  CAS  Google Scholar 

  61. Lalani AS, Masters J, Graham K, Liu L, Lucas A, McFadden G (1999) Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-Tl, during myxoma virus pathogenesis. Virology 256: 233

    PubMed  CAS  Google Scholar 

  62. Lalani AS, Masters J, Zeng W, Barrett J, Pannu R, Everett H, Arendt CW, McFadden G (1999) Use of chemokine receptors by poxviruses. Science 286: 1968

    PubMed  CAS  Google Scholar 

  63. Lee B, Doranz BJ, Rana S, Yi Y, Mellado M, Frade JM, Martinez AC, O’Brien SJ, Dean M, Collman RG, Doms RW (1998) Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J Virol 72: 7450

    PubMed  CAS  Google Scholar 

  64. Libert F, Cochaux P, Beckman G, Samson M, Aksenova M, Cao A, Czeizel A, Claustres M, Rua C de la, Ferrari M, Ferrée C, Glover G, Grinde B, Guran S, Kucinskas V, Lavinha J, Mercier B, Ogur G, Peltonen L, Rosatelli C, Schwartz M, Spitsyn V, Timar L, Beckman L, Parmentier M, Vassart G (1998) The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet 7: 399

    PubMed  CAS  Google Scholar 

  65. Lin R, Tarr PE, Jones TC (1995) Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases. Clin Infect Dis 21: 1439

    PubMed  CAS  Google Scholar 

  66. Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X, Takamatsu JK, Saito H, Ishikawa Y, Akaza T, Juji T, Takebe Y, Ohishi T, Fukutake K, Maruyama Y, Yashiki S, Sonoda S, Nakamura T, Nagai Y, Iwamoto A, Shioda T (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 96: 4581

    PubMed  CAS  Google Scholar 

  67. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367

    PubMed  CAS  Google Scholar 

  68. Mangano A, Kopka J, Batalla M, Bologna R, Sen L (2000) Protective effect of CCR2-64I and not of CCR5-delta32 and SDFI-3’A in pediatric HIV-1 infection. J Acquir Immune Defic Syndr 23: 52

    PubMed  CAS  Google Scholar 

  69. Margolis LB, Glushakova S, Grivel JC, Murphy PM (1998) Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemo-kines. J Clin Invest 101: 1876

    PubMed  CAS  Google Scholar 

  70. Mariani R, Wong S, Mulder LC, Wilkinson DA, Reinhart AL, LaRosa G, Nibbs R, O’Brien TR, Michael NL, Connor RI, Macdonald M, Busch M, Koup RA, Landau NR (1999) CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function. J Virol 73: 2450

    PubMed  CAS  Google Scholar 

  71. Martin NT, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, Lee B, Doms RW, Margolick J, Buchbinder S, Goedert JJ, O’Brien TR, Hilgartner MW, Vlahov D, O’Brien SJ, Carrington M (1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282: 1907

    PubMed  CAS  Google Scholar 

  72. McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, Murphy PM (1998) CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 352: 866

    PubMed  CAS  Google Scholar 

  73. Mebatsion T, Finke S, Weiland F, Conzelmann KK (1997) A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells. Cell 90: 841

    PubMed  CAS  Google Scholar 

  74. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, Ana AM de, Martinez AC (1999) Chemokine control of HIV-1 infection. Nature 400: 723

    PubMed  CAS  Google Scholar 

  75. Miller LH, Mason SJ, Clyde DF, McGinnissi MH (1976) The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 295: 302

    PubMed  CAS  Google Scholar 

  76. Mossman K, Nation P, Macen J, Garbutt M, Lucas A, McFadden G (1996) Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology 215: 17

    PubMed  CAS  Google Scholar 

  77. Mummidi S, Ahuja SS, Gonzalez E, Anderson SA, Santiago EN, Stephan KT, Craig FE, O’Connell P, Tryon V, Clark RA, Dolan MJ, Ahuja SK (1998) Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 4: 786

    PubMed  CAS  Google Scholar 

  78. Murakami T, Zhang TY, Koyanagi Y, Tanaka Y, Kim J, Suzuki Y, Minoguchi S, Tamamura H, Waki M, Matsumoto A, Fujii N, Shida H, Hoxie JA, Peiper SC, Yamamoto N (1999) Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection. J Virol 73: 7489

    PubMed  CAS  Google Scholar 

  79. Nguyen GT, Carrington M, Beeler JA, Dean M, Aledort LM, Blatt PM, Cohen AR, DiMichele D, Eyster ME, Kessler CM, Konkle B, Leissinger C, Luban N, O’Brien SJ, Goedert JJ, O’Brien TR (1999) Phe-notypic expressions of CCR5-delta32/delta32 homozygosity. J Acquir Immune Defic Syndr 22: 75

    PubMed  CAS  Google Scholar 

  80. Nickel RG, Casolaro V, Wahn U, Beyer K, Barnes KC, Plunkett BS, Freidhoff LR, Sengler, C, Plitt JR, Schleimer RP, Caraballo L, Naidu RP, Levett PN, Beaty TH, Huang SK (2000) Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 164: 1612

    PubMed  CAS  Google Scholar 

  81. O’Brien TR, McDermott DH, Ioannidis JP, Carrington M, Murphy PM, Havlir DV, Richman DD (2000) Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy. AIDS 14:821

    PubMed  CAS  Google Scholar 

  82. O’Brien TR, Winkler C, Dean M, Nelson JA, Carrington M, Micael NL, White GN (1997) HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 349: 1219

    PubMed  CAS  Google Scholar 

  83. Olson WC, Rabut GE, Nagashima KA, Tran DN, Anselma DJ, Monard SP, Segal JP, Thompson DA, Kajumo F, Guo Y, Moore JP, Maddon PJ, Dragic T (1999) Differential inhibition of human immunodeficiency virus type 1 fusion, gpl20 binding, and CC-chemokine activity by monoclonal antibodies to CCR5. J Virol 73: 4145

    PubMed  CAS  Google Scholar 

  84. Oravecz T, Pall M, Roderiquez G, Gorrell MD, Ditto M, Nguyen NY, Boykins R, Unsworth E, Norcross MA (1997) Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med 186: 1865

    PubMed  CAS  Google Scholar 

  85. Palacios E, Digilio L, McClure HM, Chen Z, Marx PA, Goldsmith MA, Grant RM (1998) Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus. Curr Biol 8: 943

    PubMed  CAS  Google Scholar 

  86. Parry BC, Simas JP, Smith VP, Stewart CA, Minson AC, Efstathiou S, Alcami A (2000) A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 191: 573

    PubMed  CAS  Google Scholar 

  87. Paxton WA, Martin SR, Tse D, O’Brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, Koup RA (1996) Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat Med 2: 412

    PubMed  CAS  Google Scholar 

  88. Penfold ME, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW, Schall TJ (1999) Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci USA 96: 9839

    PubMed  CAS  Google Scholar 

  89. Pleskoff O, Treboute C, Brelot A, Heveker N, Seman M, Alizon M (1997) Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 276: 1874

    PubMed  CAS  Google Scholar 

  90. Quillent C, Oberlin E, Braun J, Rousset D, Gonzalez CG, Metais P, Montagnier L, Virelizier JL, Arenzana SF, Beretta A (1998) HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet 351: 14

    PubMed  CAS  Google Scholar 

  91. Rodriguez-Frade JM, Vila-Coro AJ, Ana AM de, Albar JP, Martinez AC, Mellado M (1999) The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc Natl Acad Sci USA 96: 3628

    PubMed  CAS  Google Scholar 

  92. Rutledge BJ, Rayburn H, Rosenberg R, North RJ, Gladue RP, Corless CL, Rollins BJ (1995) High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol 155: 4838

    PubMed  CAS  Google Scholar 

  93. Saederup N, Lin YC, Dairaghi DJ, Schall TJ, Mocarski ES (1999) Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci USA 96: 10881

    PubMed  CAS  Google Scholar 

  94. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382: 722

    PubMed  CAS  Google Scholar 

  95. Schnell MJ, Johnson JE, Buonocore L, Rose JK (1997) Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell 90: 849

    PubMed  CAS  Google Scholar 

  96. Schols D, Este JA, Henson G, De Clercq E (1997) Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4. Antiviral Res 35: 147

    PubMed  CAS  Google Scholar 

  97. Schols D, Proost P, Struyf S, Wuyts A, De Meester I, Scharpe S, Van Damme J, De Clercq E (1998) CD26-processed RANTES(3–68), but not intact RANTES, has potent anti-HIV-1 activity. Antiviral Res 39:175

    PubMed  CAS  Google Scholar 

  98. Simonet WS, Hughes TM, Nguyen HQ, Trebasky LD, Danilenko DM, Medlock ES (1994) Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J Clin Invest 94: 1310

    PubMed  CAS  Google Scholar 

  99. Sironi M, Guglielmotti A, Polentarutti N, Fioretti F, Milanese C, Romano M, Vigini C, Coletta I, Sozzani S, Bernasconi S, Vecchi A, Pinza M, Mantovani A (1999) A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1. Eur Cytokine Netw 10: 437

    PubMed  CAS  Google Scholar 

  100. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O’Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O’Brien SJ (1997) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277: 959

    PubMed  CAS  Google Scholar 

  101. Steinberger P, Andris-Widhopf J, Buhler B, Torbett BE, Barbas CF 3rd (2000) Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion. Proc Natl Acad Sci USA 97: 805

    PubMed  CAS  Google Scholar 

  102. Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, Winkler C, Huttley GA, Allikmets R, Schriml L, Gerrard B, Malasky M, Ramos MD, Morlot S, Tzetis M, Oddoux C, Giovine FS di, Nasioulas G, Chandler D, Aseev M. Hanson M, Kalaydjieva L, Glavac D, Gasparini P, Kanavakis E, Claustres M, Kambouris M, Ostrer H, Duff G, Baranov V, Sibul H, Metspalu A, Goldman D, Martin N, Duffy D, Schmidtke J, Estivill X, O’Brien SJ, Dean M (1998) Dating the origin of the CCR5-delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet 62: 1507

    PubMed  CAS  Google Scholar 

  103. Swingler S, Mann A, Jacque J, Brichacek B, Sasseville VG, Williams K, Lackner AA, Janoff EN, Wang R, Fisher D, Stevenson M (1999) HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med 5: 997

    PubMed  CAS  Google Scholar 

  104. Tamamura H, Xu Y, Hattori T, Zhang X, Arakaki R, Kanbara K, Omagari A, Otaka A, Ibuka T, Yamamoto N, Nakashima H, Fujii N (1998) A low-molecular weight inhibitor against the chemo-kine receptor CXCR4: a strong anti-HIV peptide T 140. Biochem Biophys Res Commun 253: 877

    PubMed  CAS  Google Scholar 

  105. Tournamille C, Colin Y, Cartron JP, Le Van Kim C (1995) Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 10: 224

    PubMed  CAS  Google Scholar 

  106. Valdez H, Purvis SF, Lederman MM, Fillingame M, Zimmerman PA (1999) Association of the CCR5delta32 mutation with improved response to antiretroviral therapy. JAMA 282: 734

    PubMed  CAS  Google Scholar 

  107. Van Rij RP, Broersen S, Goudsmit J, Coutinho RA, Schuitemaker H (1998) The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV infection. AIDS 12: F85

  108. Voevodin A, Samilchuk E, Dashti S (1999) Frequencies of SDF-1 chemokine, CCR-5, and CCR-2 chemokine receptor gene alleles conferring resistance to human immunodeficiency virus type 1 and AIDS in Kuwaitis. J Med Virol 58: 54

    PubMed  CAS  Google Scholar 

  109. Vogels MT, Lindley IJ, Curfs JH, Eling WM, Meer JW van der (1993) Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice. Antimicrob Agents Chemother 37:276

    PubMed  CAS  Google Scholar 

  110. Weiss JM, Nath A, Major EO, Berman JW (1999) HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. J Immunol 163: 2953

    PubMed  CAS  Google Scholar 

  111. Weissman D, Rabin RL, Arthos J, Rubbert A, Dybul M, Swofford R, Venkatesan S, Farber JM, Fauci AS (1997) Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389: 981

    PubMed  CAS  Google Scholar 

  112. White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA, Widdowson K, Foley JJ, Martin LD, Griswold DE, Sarau HM (1998) Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 273: 10095

    PubMed  CAS  Google Scholar 

  113. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O’Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, O’Brien SJ (1998) Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 279: 389

    PubMed  CAS  Google Scholar 

  114. Yang BT, Chen SC, Leach MW, Manfra D, Homey B, Wiekowski M, Sullivan L, Jenh CH, Narula SK, Chensue SW, Lira SA (2000) Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi’s sarcoma. J Exp Med 191:445

    PubMed  CAS  Google Scholar 

  115. Yang XD, Corvalan JR, Wang P, Roy CM, Davis CG (1999) Fully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states. J Leukoc Biol 66: 401

    PubMed  CAS  Google Scholar 

  116. Zhang YJ, Dragic T, Cao Y, Kostrikis L, Kwon DS, Littman DR, KewalRamani VN, Moore JP (1998) Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro. J Virol 72: 9337

    PubMed  CAS  Google Scholar 

  117. Zhou Y, Kurihara T, Ryseck RP, Yang Y, Ryan C, Loy J, Warr G, Bravo R (1998) Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J Immunol 160: 4018

    PubMed  CAS  Google Scholar 

  118. Zimmerman PA, Buckler WA, Alkhatib G, Spalding T, Kubofcik J, Combadiere C, Weissman D, Cohent O, Rubber A, Lam G, Vaccarezza M, Kennedy PE, Kumaraswami V, Giorgi JV, Detels R, Hunter J, Chopek M, Berger EA, Fauci AS, Nutman TB, Murphy PM (1997) Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 3: 23

    PubMed  CAS  Google Scholar 

  119. Zisman DA, Kunkel SL, Strieter RM, Tsai WC, Bucknell K, Wilkowski J, Standiford TJ (1997) MCP-1 protects mice in lethal endotoxemia. J Clin Invest 99: 2832

    PubMed  CAS  Google Scholar 

  120. Zou P, Isegawa Y, Nakano K, Haque M, Horiguchi Y, Yamanishi K (1999) Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J Virol 73: 5926

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Signaling Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 10 Center Drive, Bldg. 10, Room 11N113, 20892-1886, Bethesda, MD, USA

    David H. McDermott & Philip M. Murphy

Authors
  1. David H. McDermott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip M. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McDermott, D.H., Murphy, P.M. Chemokines and their receptors in infectious disease. Springer Semin Immunopathol 22, 393–415 (2000). https://doi.org/10.1007/s002810000052

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002810000052

Keywords

Search

Navigation